solution-oriented approach program: The solution-focused nursing intervention applied to the experimental group in the study was planned as individual sessions, consisting of one session per week, lasting a total of six weeks. The interventions were based on the principles of solution-focused brief therapy, focusing on the individual's strengths, past coping experiences, and current resources. The interviews aimed to identify exceptions, build positive future expectations, set small but achievable goals, strengthen hope, and increase the individual's ability to utilize their internal resources. Each session used structured open-ended questions, scaling techniques, and future-oriented solution scenarios to support the individual's psychosocial adjustment and motivation for treatment.
Study summary
The aim of this study is to evaluate the effects of a solution-focused approach-based individual intervention on psychosocial adjustment and treatment adherence in individuals diagnosed with schizophrenia.
The study will be conducted as a randomized controlled trial including 60 clinically stable individuals diagnosed with schizophrenia according to DSM-5 criteria and registered at a Community Mental Health Center affiliated with a university hospital. Participants will be randomly assigned to an experimental group (n=30) and a control group (n=30).
The experimental group will receive one individual solution-focused therapy session per week for six weeks. The control group will receive usual care only. Data will be collected using a Personal Information Form, the Psychosocial Adjustment Scale (PSSAS), and the Medication Adherence Scale (MARS).
Eligibility
Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria:
* Having been diagnosed with schizophrenia according to DSM-5 diagnostic criteria,
Being between 18 and 65 years of age,
Being literate and verbally communicative,
Being clinically stable (not exhibiting symptoms of acute psychosis),
Being registered with a Community Mental Health Center (CMHC) and receiving regular services,
Being cognitively competent enough to participate in individual interviews during the research process,
Being an individual currently receiving psychiatric treatment and taking medication,
Agreeing to participate voluntarily in the study and signing a written informed consent form.
Exclusion Criteria:
* those who do not meet the inclusion criteria
Primary outcome measure(s)
pretest (6-week solution-focused approach before the intervention) — Baseline (1 week before intervention)] 1\. Psychosocial Adjustment (PSSAS)
Description: Measured with the Psychosocial Adjustment Scale (PSSAS), which assesses social relationships, daily life management, and coping with stress. Scores range from 0 to 180; higher scores indicate better psychosocial adjustment.
Time Frame: Baseline (within 1 week before intervention)
Unit of Measure: Total score (0-180)
pretest (6-week solution-focused approach before the intervention) — Baseline (within 1 week before intervention) 2\. Medication Adherence (MARS)
Description: Measured with the Medication Adherence Scale (MARS), which assesses adherence to prescribed pharmacological treatment. Scores range from 0 to 10; higher scores indicate better medication adherence.
Time Frame: Baseline (within 1 week before intervention)
Unit of Measure: Total score (0-10)
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.